|
Gliomas
|
|
Home > Database
> Prognosis and
Outcome >
Gliomas
|
|
|
Contents
|
|
|
|
Gliomas
|
|
|
|
|
Basso U, Monfardini S, Brandes AA
Recommendations for the
management of malignant gliomas in the elderly
Expert Rev Anticancer Ther. 2003 Oct;3(5):643-54
|
|
Batistatou A, Kyzas PA, Goussia A, Arkoumani E,
Voulgaris S, Polyzoidis K, Agnantis NJ, Stefanou D.
Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and
prognosis in brain glial tumours.
J Neurooncol. 2006 Mar;77(1):17-23. Epub 2005 Nov 15.
.JPG)
Abstract
|
|
|
Bisdas S, Kirkpatrick M, Giglio P, Welsh C, Spampinato MV, Rumboldt Z
Cerebral
Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready
for the Prime Time in Predicting Short-Term Outcome and Recurrent Disease?
AJNR
Am J Neuroradiol. 2009 Jan 29. [Epub ahead of print]
Abstract
|
|
P. D.
Brown, K. V. Ballman, T. A. Rummans, M. J. Maurer, J. A. Sloan, B. F.
Boeve, R. M. Arusell, M. M. Clark, J.
C. Buckner
Prospective NCCTG quality of life (QOL)
study in adult newly diagnosed high-grade gliomas (HGG)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1524
|
| |
Brown PD, Buckner JC, O'Fallon JR, Iturria NL, O'Neill BP, Brown
CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG
Importance
of baseline mini-mental state examination as a prognostic factor for patients
with low-grade glioma
Int J Radiat Oncol Biol Phys. 2004
May 1;59(1):117-25
|
|
Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher
MJ, Tochner ZA, Rorke L,
Sutton LN, Phillips PC, Shu HK
Near complete surgical resection predicts a favorable outcome
in pediatric patients with nonbrainstem, malignant gliomas: results from a
single center in the magnetic resonance imaging era
Cancer. 2004 Aug 15;101(4):817-24
|
| |
Buckner JC
Factors influencing survival in high-grade gliomas
Semin Oncol. 2003 Dec;30(6 Suppl 19):10-4
|
|
J.
C. Buckner, B. W.
Scheithauer, J. R. O'Fallon, P. Schaefer, C. Giannini, K. Ballman, R. Jenkins
p53, EGFR, and PTEN as markers of diagnosis and
prognosis in patients with anaplastic glioma enrolled in NCCTG clinical trials
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
393
|
| |
Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken
R, Ross BD, Chenevert TL, Lawrence TS
Clinical investigation survival
prediction in high-grade gliomas by MRI perfusion before and during early stage
of RT
Int
J Radiat Oncol Biol Phys. 2005 Nov 17; [Epub ahead of print]
|
|
K. Carson, S. A. Grossman,
J. D. Fisher and E. Shaw
Prognostic factors for survival in
adult patients with recurrent glioma enrolled on New Approaches to Brain Tumor
Therapy (NABTT) CNS Consortium phase I and II clinical trials
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1509
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1509
|
|
WJ Curran Jr, CB Scott, J Horton, JS Nelson, AS Weinstein, AJ Fischbach, CH
Chang, M Rotman, SO Asbell and RE Krisch
Recursive partitioning analysis of prognostic factors in three Radiation
Therapy Oncology Group malignant glioma trials
Journal Of The National Cancer Institute, Volume 85, CNO 9 :
May 5, 1993, 704-710
|
|
Curran WJ
Jr, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K,
Fischbach AJ, Yakar D, Schwade JG, et al.
Survival
comparison of radiosurgery-eligible and -ineligible malignant glioma patients
treated with hyperfractionated radiation therapy and carmustine: a report of
Radiation Therapy Oncology Group 83-02
J Clin Oncol. 1993 May;11(5):857-62
|
| |
De
Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I,
Brotchi J, Goldman S
Positron emission tomography with
injection of methionine as a prognostic factor in glioma
J
Neurosurg. 2001 Nov;95(5):746-50)
|
|
|
Ducray
F, Idbaih A, Wang XW, Cheneau C, Labussiere M, Sanson M.
Predictive and prognostic
factors for gliomas.
Expert Rev Anticancer Ther.
2011 May;11(5):781-9.
Abstract |
.gif) Related articles
|
|
A.
Flowers
Management of malignant
gliomas at Hartford Hospital: Patterns of care and outcomes
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
464)
|
| |
E.
Galanis, M. J. Maurer, K. V. Ballman, J. O'Fallon, R. Sykora, R. Castillo,
J. C. Buckner, B. J. Erickson
Validation of neuroradiologic response
assessment in gliomas: RECIST (1D) vs 2D measurements vs computer-assisted tumor
area vs volume
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
423
|
|
|
Gennadi V. Glinsky, Olga
Berezovska and Anna B. Glinskii
Microarray analysis identifies a death-from-cancer signature predicting
therapy failure in patients with multiple types of cancer
J. Clin. Invest. 115:1503-1521 (1 June 2005)
Abstract
| .png)
Full
Text | .png)
R eprint
|
|
|
Gupta
T, Sarin R, Jalali R, Sharma S, Kurkure P, Goel A
A pragmatic clinicopathobiological grouping/staging system for gliomas:
Proposal of the Indian TNM subcommittee on brain tumors
Neurol India. 2009 May-Jun;57(3):247-51
Abstract |
Full Text |
Reprint
|
|
|
Halperin EC
Malignant gliomas in older
adults with poor prognostic signs. Getting nowhere, and taking a long time
to do it
Oncology (Huntingt). 1995 Mar;9(3):229-34; discussion 237-8, 243
|
|
Huncharek
M, Muscat J
Treatment
of recurrent high grade astrocytoma; results of a systematic review of 1,415
patients
Anticancer Res. 1998 Mar-Apr; 18(2B): 1303-11
|
|
Yasushi
Ino,
M.D., Magdalena
C. Zlatescu,
M.D., Hikaru
Sasaki,
M.D., Ph.D.,
David
R. Macdonald,
M.D., Anat
O. Stemmer-Rachamimov,
M.D., Sarah
Jhung,
B.S., David
A. Ramsay,
M.D., Andreas
Von Deimling,
M.D., David
N. Louis,
M.D., And
J. Gregory
Cairncross,
M.D.
Long
survival and therapeutic responses in patients with histologically
disparate high-grade gliomas demonstrating chromosome 1p loss
J Neurosurg.,
92:983–990, June 2000
|
|
|
Iwamoto FM, Nicolardi L, Demopoulos A,
Barbashina V, Salazar P, Rosenblum M, Hormigo A.
Clinical relevance of 1p and 19q deletion for patients with WHO grade 2
and 3 gliomas
J Neurooncol.
2008 Mar 15; [Epub ahead of print]
Abstract
|
|
Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic
J, Nikolic N
Clinical prognostic factors in patients with
malignant glioma treated with combined modality approach
Am J Clin Oncol. 2004 Apr;27(2):195-204
|
|
Klein M,
Postma TJ, Taphoorn MJ, Aaronson NK, Vandertop WP, Muller M, Van Der Ploeg HM,
Heimans JJ
The
prognostic value of cognitive functioning in the survival of patients with
high-grade glioma
Neurology. 2003 Dec 23;61(12):1796-8
|
| |
Kuznetsov YE, Caramanos Z, Antel SB, Preul MC, Leblanc R,
Villemure JG, Pokrupa R, Olivier A, Sadikot A, Arnold DL
Proton magnetic resonance spectroscopic imaging can
predict length of survival in patients with supratentorial gliomas
Neurosurgery. 2003 Sep;53(3):565-76
|
|
B. E. Lally, J. M. Colasanto,
J. P. S. Knisely
The prognostic effect of hemoglobin levels on
survival for patients with high-grade gliomas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1565)
|
|
|
Law
M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC,
Golfinos JG, Zagzag D, Johnson G.
Gliomas: predicting time to progression or survival with cerebral blood
volume measurements at dynamic susceptibility-weighted contrast-enhanced
perfusion MR imaging
Radiology. 2008 May;247(2):490-8.
Epub 2008 Mar 18
Abstract |
.gif) News
|
|
Laws ER, Parney IF, Huang W, Anderson F, Morris AM,
Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S;
Glioma Outcomes Investigators
Survival following surgery
and prognostic factors for recently diagnosed malignant glioma: data from
the Glioma Outcomes Project
J Neurosurg. 2003 Sep;99(3):467-73
|
|
Ljubimova JY, Fugita M, Khazenzon NM, Das A, Pikul BB, Newman D, Sekiguchi K,
Sorokin LM, Sasaki T, Black KL
Association between laminin-8 and glial tumor grade,
recurrence, and patient survival
Cancer. 2004 Aug 1;101(3):604-12
|
|
|
Mathiesen T, Peredo I, Lönn S.
Two-year survival of low-grade and high-grade glioma patients using data
from the Swedish Cancer Registry.
Acta Neurochir (Wien). 2010 Dec 15;. [Epub ahead of print]
Abstract |
Related articles
|
|
Murovic
J, Turowski K, Wilson CB, Hoshino T, Levin V
Computerized
tomography in the prognosis of malignant cerebral gliomas
J
Neurosurg 1986 Dec;65(6):799-806
|
|
Satoshi
Nakasu, Tadateru Fukami, Kazumi Baba, Masayuki Matsuda
Immunohistochemical
study for O6-methylguanine-DNA methyltransferase in the
non-neoplastic and neoplastic components of gliomas
Journal
of Neuro-Oncology, 70(3):
333-340, December 2004. (Abstract+)
|
| |
Nieder C, Grosu AL, Molls M
A
comparison of treatment results for recurrent malignant gliomas
Cancer Treat Rev. 2000 Dec; 26(6): 397-409
|
|
M.V. Padma, S. Said,
M. Jacobs, D.R. Hwang, K. Dunigan, M. Satter, B. Christian, J. Ruppert, T.
Bernstein, G. Kraus, J.C. Mantil
Prediction of Pathology and Survival by FDG PET in Gliomas
Journal of Neuro-Oncology, 64 (3): 227-237, September 2003
|
|
Ian F. Pollack, Ronald
L. Hamilton, Robert W. Sobol, Judith Burnham,
Allan J. Yates, Emiko J. Holmes, Tianni
Zhou, Jonathan L. Finlay
O6-Methylguanine-DNA
Methyltransferase Expression Strongly Correlates With Outcome in Childhood
Malignant Gliomas: Results From the CCG-945 Cohort
Journal of Clinical Oncology, Vol 24, No 21 (July 20), 2006: pp. 3431-3437;
DOI: 10.1200/JCO.2006.05.7265
|
|
R.
D. Rao, R.
Jenkins, B. W. Scheithauer, J. R. O'Fallon, A. Furth, A. Furth, N. Iturria, P.
Schaefer, J. C. Buckner
Correlations
between cytological subtypes and cytogenetic aberrations in high grade
gliomas
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
422
|
|
S.
N. Raval, B.
Gu, J. J. Raizer, M. K. Rosenblum, D. Banerjee, J. R.
Bertino, L. M. DeAngelis
Methylation of MGMT promotor, the DNA repair gene
as an independent prognostic factor for malignant glioma
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
452
|
|
|
Russell
SM, Elliott R, Forshaw D, Golfinos JG, Nelson PK, Kelly PJ
Glioma
vascularity correlates with reduced patient survival and increased
malignancy
Surg Neurol. 2009 Mar 27. [Epub
ahead of print]
Abstract
|
|
Andrea
Salmaggi, Marica Eoli, Simona
Frigerio, Antonio
Silvani, Maurizio Gelati, Elena Corsini, Giovanni Broggi, Amerigo Boiardi
Intracavitary
VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma
Journal of Neuro-Oncology,
62 (3): 297-303, May
2003
|
|
|
Sanai
N, Berger MS.
Glioma extent of resection and its impact on patient outcome
Neurosurgery. 2008
Apr;62(4):753-64
Abstract |
Full
Text |
Reprint
|
|
Shono T,
Tofilon PJ, Bruner JM, Owolabi O, Lang FF
Cyclooxygenase-2
expression in human gliomas: prognostic significance and molecular correlations
Cancer Res 2001 Jun 1;61(11):4375-81
|
|
Stewart LA
Chemotherapy in adult
high-grade glioma: a systematic review and meta-analysis of individual
patient data from 12 randomised trials
Lancet. 2002 Mar 23;359(9311):1011-8
|
| |
Stupp R, Janzer RC, Hegi ME, Villemure JG, Mirimanoff RO
Prognostic factors for low-grade gliomas
Semin Oncol. 2003 Dec;30(6 Suppl 19):23-8
|
|
Takahashi Y,
Imahori Y, Mineura K
Prognostic
and therapeutic indicator of fluoroboronophenylalanine positron emission
tomography in patients with gliomas
Clin Cancer Res. 2003 Dec 1;9(16):5888-95
|
|
Avelina
Tortosa, Nuria Vinolas, Salvador Villa, Eugenia Verger, Juan M Gil, Marta Brell,
Lluis Caral, Teresa Pujol, Juan Jose Acebes, Teresa Ribalta, Isidre Ferrer,
Francesc Graus
Prognostic
implication of clinical, radiological, and pathological features in patients
with anaplastic glioma
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. 304
|
|
|
Tu Y, Lu J, Fu J, Cao Y, Fu G, Kang R, Tian X, Wang B.
Over-expression of Neuroepithelial-transforming Protein 1 Confers Poor
Prognosis of Patients with Gliomas
Jpn J Clin Oncol. 2010 Mar 18;. [Epub ahead of print]
Abstract
|
|
Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J
Debulking or biopsy of
malignant glioma in elderly people - a randomised study
Acta Neurochir (Wien). 2003 Jan;145(1):5-10
|
|
J.
H. Wisoff, A.
Sanford, E. Holmes, R. Sposto, L. Kun, L. Heier, P. Burger, A. Yates
Impact of
surgical resection on low grade gliomas of childhood: A report from the
CCG9891/POG9130 low grade astrocytoma study
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
401
|
|
Wong
ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung
WK
Outcomes
and prognostic factors in recurrent glioma patients enrolled onto phase II
clinical trials
J Clin
Oncol. 1999 Aug;17(8):2572
|
|
Yi-Hong Zhou, Kenneth R. Hess, W. K. Alfred
Yung
Prognostic model for glioma patients
Proceedings of the AACR, Volume 45, March 2004, Abstract Number: 1078
|
|
Yi-Hong Zhou, Fang Tan, Kenneth R. Hess
and W. K. Alfred Yung
The Expression of PAX6, PTEN, Vascular Endothelial Growth Factor, and
Epidermal Growth Factor Receptor in Gliomas. Relationship to Tumor Grade and Survival
Clinical Cancer Research Vol. 9, 3369-3375, August 2003
|
|
|
Zeppernick F, Ahmadi R, Campos B, Dictus C,
Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC
Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
Clin Cancer Res. 2008 Jan 1;14(1):123-9
Abstract
|
|
Elderly
Patients |
|
|
|
Ewelt
C, Goeppert M, Rapp M, Steiger HJ, Stummer W, Sabel M.
Glioblastoma
multiforme of the elderly: the prognostic effect of resection on survival.
J
Neurooncol. 2010 Oct 16. [Epub ahead of print]
Abstract |
Full Text |
Reprint |
Related articles
|
|
Spinal Cord Gliomas |
|
|
|
Kahn
J, Loeffler JS, Niemierko A, Chiocca EA, Batchelor T, Chakravarti A.
Long-Term
Outcomes of Patients with Spinal Cord Gliomas Treated by Modern Conformal
Radiation Techniques.
Int
J Radiat Oncol Biol Phys. 2010 Oct 13. [Epub ahead of print]
Abstract |
News
|
Related articles
|
|
Jen-Ho Tseng, Ming-Yuan Tseng
Survival Analysis of 81 Children with Primary
Spinal Gliomas: A Population-Based Study
Pediatr Neurosurg. 2006 Oct;42(6):347-53.
Abstract
|
|
|
|
